Israel's Teva Pharmaceuticals Reports Q4 Losses

The company attributes the decline in profit and revenue after sales of its drug Copaxone fell as a result of competition.

comments Print
Teva Pharmaceutical Industries, the world's largest generics drugmaker, reported a decline in fourth-quarter profit and revenue as sales of its top drug Copaxone fell in the wake of competition.